Literature DB >> 34365812

Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.

Jung-Im Shin1, Alex R Chang2, Morgan E Grams1, Josef Coresh1, Shoshana H Ballew1, Aditya Surapaneni1, Kunihiro Matsushita1, Henk J G Bilo3, Juan J Carrero4, Gabriel Chodick5, Kenn B Daratha6, Simerjot K Jassal7, Girish N Nadkarni8, Robert G Nelson9, Christoph Nowak10, Nikita Stempniewicz11, Keiichi Sumida12, Jamie P Traynor13, Mark Woodward1,14, Yingying Sang1, Ron T Gansevoort15.   

Abstract

[Figure: see text].

Entities:  

Keywords:  albuminuria; blood pressure; diabetes mellitus; hypertension; kidney; prevalence risk

Mesh：

Substances：

Year:  2021        PMID： 34365812      PMCID： PMC8429211          DOI： 10.1161/HYPERTENSIONAHA.121.17323

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


  24 in total

1.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

2.  Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

Authors:  Henri Afghahi; Jan Cederholm; Björn Eliasson; Björn Zethelius; Soffia Gudbjörnsdottir; Henrik Hadimeri; Maria K Svensson
Journal:  Nephrol Dial Transplant       Date:  2010-09-03       Impact factor: 5.992

Review 3.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Authors:  Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 29.983

Review 4.  11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021.

Authors: 
Journal:  Diabetes Care       Date:  2021-01       Impact factor: 19.112

5.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245

6.  Dapagliflozin in Patients with Chronic Kidney Disease.

Authors:  Hiddo J L Heerspink; Bergur V Stefánsson; Ricardo Correa-Rotter; Glenn M Chertow; Tom Greene; Fan-Fan Hou; Johannes F E Mann; John J V McMurray; Magnus Lindberg; Peter Rossing; C David Sjöström; Roberto D Toto; Anna-Maria Langkilde; David C Wheeler
Journal:  N Engl J Med       Date:  2020-09-24       Impact factor: 91.245

7.  Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.

Authors:  Klaus Klausen; Knut Borch-Johnsen; Bo Feldt-Rasmussen; Gorm Jensen; Peter Clausen; Henrik Scharling; Merete Appleyard; Jan Skov Jensen
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

8.  Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Robert H Hopkins; Donna E Sweet; Melissa Starkey; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-12-17       Impact factor: 25.391

9.  2020 International Society of Hypertension Global Hypertension Practice Guidelines.

Authors:  Thomas Unger; Claudio Borghi; Fadi Charchar; Nadia A Khan; Neil R Poulter; Dorairaj Prabhakaran; Agustin Ramirez; Markus Schlaich; George S Stergiou; Maciej Tomaszewski; Richard D Wainford; Bryan Williams; Aletta E Schutte
Journal:  Hypertension       Date:  2020-05-06       Impact factor: 10.190

10.  Cohort profile: the chronic kidney disease prognosis consortium.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Brad C Astor; Paul E de Jong; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey; Adeera Levin; Chi-Pang Wen; Mark Woodward; Josef Coresh
Journal:  Int J Epidemiol       Date:  2012-12-12       Impact factor: 7.196
View more
  2 in total

1.  Identifying Distinct Risk Thresholds of Glycated Hemoglobin and Systolic Blood Pressure for Rapid Albuminuria Progression in Type 2 Diabetes From NHANES (1999-2018).

Authors:  Jiahui Xu; Yan Xue; Qingguang Chen; Xu Han; Mengjie Cai; Jing Tian; Shenyi Jin; Hao Lu
Journal:  Front Med (Lausanne)       Date:  2022-06-20

2.  Usability Testing of the Kidney Score Platform to Enhance Communication About Kidney Disease in Primary Care Settings: Qualitative Think-Aloud Study.

Authors:  Delphine S Tuot; Susan T Crowley; Lois A Katz; Joseph Leung; Delly K Alcantara-Cadillo; Christopher Ruser; Elizabeth Talbot-Montgomery; Joseph A Vassalotti
Journal:  JMIR Form Res       Date:  2022-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.